Comparison of Bovine Lipid Extract Surfactant and Poractant Alfa Administered via LISA in Preterm Infants(28 <sup>+0</sup> to 34 <sup>+6</sup> Week) With Respiratory Distress Syndrome: A Randomized Controlled Trial
In LMIC settings, BLES and poractant alfa showed similar effectiveness for RDS management via LISA, with no difference in clinical outcomes. BLES provides a cost-effective alternative in resource-constrained neonatal care.
Authors
- Avijit Hazra (ORCID: https://orcid.org/0000-0003-3561-1365)
- Md Habibullah Sk (ORCID: https://orcid.org/0000-0001-8658-5713)
- Bijan Saha (ORCID: https://orcid.org/0000-0001-8104-9225)
- Ashadur Zamal (ORCID: https://orcid.org/0000-0003-0990-392X)
Institutions
- Institute of Post Graduate Medical Education and Research (IN)
Publication Details
- Journal
- Pediatric Pulmonology
- Published
- 2025-09-01
- DOI
- https://doi.org/10.1002/ppul.71281
- Citations
- 2
- Primary Topic
- Neonatal Respiratory Health Research
- Type
- article
- Field-Weighted Citation Impact
- 3.04